MULTI-YEAR DYNAMICS OF SPREAD OF HEPATITIS C VIRUS GENOTYPES IN MOSCOW REGION

Cover Page


Cite item

Full Text

Abstract

Aim. Determine spread of hepatitis C vims genotypes, circulating in Moscow Region over the last decade. Materials and methods. The presence of HCV RNA, genotype and subtype of the vims were determined in blood sera samples obtained in 2006 - 2014 from 2847 individuals with the presence of HCV infection, who had or did not have injectable dmg administration in anamnesis. Results, lb and 3a remain the main subtypes, circulating in the population over the last decade. A notable reduction of la subtype circulation took place among injectable dmg users (IDU). Recombinant form RFl_2k/lb of hepatitis vims is present only among this risk group and constitutes 2% of the overall amount of subtypes in both 2007 and 2014. Genotype 4d was detected in 2014, that is not typical for Russian Federation. Genotype 3a is dominant in IDU age groups of 20 - 29 and older than 40, and in the 30 - 39 group the main - subtype lb. Phylogenetic analysis has shown the lack of certain genetic variants of subtypes lb and 3a, characteristic for IDU, that gives evidence on a wide circulation of the main subtypes of the vims in the whole population of individuals, infected by HCV. Conclusion. Spread of main genotypes/subtypes of HCV in the overall population and among IDU in Moscow remains stable over the last decade.

About the authors

O. V. Isaeva

Chumakov Institute of Poliomyelitis and Viral Encephalites

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

V. S. Kichatova

Chumakov Institute of Poliomyelitis and Viral Encephalites

Email: noemail@neicon.ru
Russian Federation

A. A. Karlsen

Chumakov Institute of Poliomyelitis and Viral Encephalites

Email: noemail@neicon.ru
Russian Federation

S. A. Solonin

Chumakov Institute of Poliomyelitis and Viral Encephalites; Sklifosovksy Research Institute of Emergency Aid

Email: noemail@neicon.ru
Russian Federation

P. N. Dmitriev

Chumakov Institute of Poliomyelitis and Viral Encephalites

Email: noemail@neicon.ru
Russian Federation

K. K. Kyuregyan

Chumakov Institute of Poliomyelitis and Viral Encephalites

Email: noemail@neicon.ru
Russian Federation

M. I. Mikhailov

Chumakov Institute of Poliomyelitis and Viral Encephalites

Email: noemail@neicon.ru
Russian Federation

References

  1. Антонова Т. В. и др. В: Онищенко Г. Г., Жебрун А. Б. (ред.). Вирусные гепатиты в РФ 2010. М3 РФ, Роспотребнадзор, Спб НИИЭМ им. Пастера, СПб, 2010.
  2. Кюрегян К.К., Михайлов М.И. Молекулярно-биологические основы контроля вирусных гепатитов. М., Икар, 2013.
  3. Калинина О.В. Молекулярно-генетические механизмы эволюции вируса гепатита С. Автореф. дисс. д.б.н. СПб, 2013.
  4. Шахгильдян И. В., Михайлов М. И., Онищенко Г. Г. Парентеральные вирусные гепатиты (эпидемиология, диагностика, профилактика). М., ГОУ ВУНМЦ М3 РФ, 2003.
  5. Demetriou V.L., Kyriakou Е., Kostrikis L.G. Near-full genome characterisation of two natural intergenotypic 2k/lb recombinant hepatitis C virus isolates. Adv. Virol. 2011, 2011: 710438.
  6. Esteban J.I., Sauleda S., Quer J. The changing epidemiology of hepatitis C vims infection in Europe. J. Hepatol. 2008, 48: 148-162.
  7. Hope V.D., Eramova I., Capurro D., Donoghoe M.C. Prevalence and estimation of hepatitis В and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol. Infect. 2014, 142:270-286.
  8. Kurbanov E, Tanaka Y., Chub E. et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RFl_2k/lb. J. Infect. Dis. 2008, 15, 198 (10): 1448-1456.
  9. Kalinina O., Norder H., Vetrov T. et al. Shift in predominating subtype of HCV from lb to 3a in St. Petersburg mediated by increase in injecting drug use. J. Med. Virol. 2001, 65: 517-524.
  10. Lidman C., Norden L., Kaberg M. et al. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender. Scand. J. Infect. Dis. 2009, 41: 679-684.
  11. Morice Y., Cantaloube J.F., Beaucourt S. et al. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J. Med. Virol. 2006, 78 (10): 1296-1303.
  12. Miihlberger N., Schwarzer R., Lettmeier B. et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health. 2009, 9: 34.
  13. Nelson P.K., Mathers B.M., Cowie B. et al. Global epidemiology of hepatitis В and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378: 571-583.
  14. Ohno T, Mizokami M. Genotyping with type-specific primers that can type HCV types 1-6. Methods in molecular medicine, Vol. 19: Hepatitis C protocols. 1998, p: 159-164.
  15. Pybus O.G., Cochrane A., Holmes E.C., Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 2005, 5 (2): 131-139.
  16. Rhodes T, Platt L., Maximova S. et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006, 101: 252-266.
  17. Sama A., Panda S. HCV in people who inject drugs: a neglected epidemic. Lancet Infect. Dis. 2015,15:4-5.
  18. Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J. Gen. Virol. 2004, 85 (11): 3173-3188.
  19. Thorpe L. E., Ouellet L. J., Hershow R. et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 2002, 155: 645-653.
  20. World Health Organization. A strategy to halt and reverse the HIV epidemic among people who inject drugs in Asia and the Pacific: 2010 - 2015, WHO Library Cataloguing, 2015.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Isaeva O.V., Kichatova V.S., Karlsen A.A., Solonin S.A., Dmitriev P.N., Kyuregyan K.K., Mikhailov M.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies